Founded in 2015, LeadsRx helps marketers understand the value of each customer touchpoint across digital, radio, TV, podcasts, streaming services, and other advertising channels, allowing them to better optimize their conversion paths, ad spend and ROI.
LeadsRx serves more than 5,000 global and local brands and agencies ranging from iHeartMedia and Casper to Cumulus Media, Diray Media and Rakuten Advertising.
The LeadsRX acquisition is Unbounce’s second in the last nine months and positions Unbounce to be able to bring the power of marketing attribution to its small and midsize business customers. Unbounce acquired Snazzy AI, a freemium AI powered copywriting tool running, in May 2021
LeadsRx is deeply committed to consumer data privacy. The company works off its proprietary technology that collects first-party data only. Unlike marketing attribution platforms of its kind, LeadsRx doesn’t rely on third-party cookies but instead develops private identity graphs for each of its clients.
“Unbounce and LeadsRx share a vision for the future of marketing that machines and marketers can work better together to produce the best results possible,” said AJ Brown, CEO and co-founder of LeadsRx.
“We’re bringing together some of the most creative and inventive engineers, marketing and customer services professionals — I’m excited for what the future holds and the innovative products we will be able to offer companies and agencies around the world.”
Brown will remain CEO of LeadsRx while reporting to Unbounce’s CEO Felicia Bochicchio but otherwise the 21-person LeadsRx team will continue to operate independently.
While Unbounce plans on bringing the value of marketing attribution to its conversion intelligence platform, LeadsRx and Unbounce will remain standalone platforms until further assessment takes place.
Unbounce is a distributed team of over 250 people and has over 100,000 customers that rely on its landing pages, copy creation, and campaign optimization tools to accelerate their ROI and grow smarter.